CrossrefInfokarte
Recommendations for testing of predictive marker HER2 in patients with invasive breast cancer. Recommendations in accordance with American Society of Clinical Oncology (ASCO) guidelines from 30th May 2018
Oncology in Clinical Practice · 2018-11-25 · 14 (5) · 272-277
DOI: 10.5603/ocp.2018.0034 ↗Abstract
Kein Abstract verfügbar.
EUVIMED